乳がん
Sibylle Loibl1, Philip Poortmans2, Monica Morrow3
1German Breast Group, Neu-Isenburg, Germany; Centre for Haematology and Oncology Bethanien, Frankfurt, Germany.
Lancet (London, England)
|April 4, 2021
まとめ
乳がんの治療は分子および免疫マーカーによって進化し,パーソナライズされたネオアジュバント療法と低濃度放射線療法が可能になりました. 先進的な標的治療薬と免疫療法は 転移性疾患に合わせた選択肢を提供しています
科学分野:
- 腫瘍学
- 分子生物学
- 免疫学
背景:
- 乳がんは世界の主要ながんであり, 分子特性により理解が進化しています
- 主なマーカーには免疫ヒストキミカル (ER,PR,HER2,Ki-67),ゲノム (BRCA1/ 2,PIK3CA),免疫マーカー (TIL,PD- L1) が含まれる.
研究 の 目的:
- 乳がんの診断と治療の進歩を強調する
- 分子プロファイルの パーソナライズド医療への移行を強調します
主な方法:
- 複数のバイオマーカーの組み合わせを含む現在の診断アルゴリズムのレビュー.
- 標的薬および免疫療法を含む新補助薬および転移性治療戦略の分析
主要な成果:
- ネオアジュバント併用療法 (HER2陽性,トリプルネガティブ) は標準的なもので,外科的緩和および治療後の戦略を指針としています.
- 内分泌療法 (5~10年) と化学療法が,ER陽性腫瘍のリスクに基づいて用いられる.
- 転移治療には,CDK4/ 6,PI3K,PARP阻害剤,および腫瘍プロファイルに合わせた抗PD- L1免疫療法が含まれています.
結論:
- 乳がんの治療は バイオマーカーの進歩により 複雑化しています
- 個別化された治療戦略が標準になりつつあります 新補助医療から転移性疾患の管理までです
関連する概念動画
What is Cancer?
12.6K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
12.6K
Disorders of the Female Reproductive System
3.4K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
3.4K
Cancer
51.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.6K
Tumor Progression
6.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.8K
Cancer Prevention
7.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.2K
Cancer Survival Analysis
508
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
508


